Clinical Trial Update: A Study to Evaluate Safety and Tolerability of Multiple Doses of MEDI-546 in Adult Subjects With Scleroderma [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 trial evaluating the safety and tolerability of multiple doses of MEDI-546 in adults with systemic sclerosis (…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• MEDI-546

Snippet

Sponsor: MedImmune LLC | Conditions: Scleroderma | Phase 1 | Status: COMPLETED